News for hackers. Stuff that matters.
Re:Compass Pathways' Phase IIb psilocybin trial shows reduce... by JohnJamesRambo on Tuesday November 09, 2021 @07:28PM (#29169507)
This sounds pretty crappy right? If I'm understanding the numbers, 25% response is about like what we get with a placebo in most studies if my memory is correct.

It sounds like they were tripping balls on 25 mg, so this is definitely in active placebo range.

From my memory:

Placebo is about 25%.

Antidepressants about 35% response rate.

Active placebo of something like atropine which makes you feel weird but isn't an antidepressant has about a 35% response rate.

https://blogs.scientificamerican.com/cross-check/are-antidep...

Re:Compass Pathways' Phase IIb psilocybin trial shows reduce... by drooby on Tuesday November 09, 2021 @09:27PM (#29170395)
I’m not sure if it makes a difference, but this study was conducted on _treatment resistant_ patients.